Newswise — Nicholas Delamere, PhD (University of Arizona) is the new president of the Association for Research in Vision and Ophthalmology, taking over from Todd Margolis, MD, PhD (University of California-San Francisco), whose one-year term ended in May.

Paul Sternberg, MD (Vanderbilt Eye Institute) will serve as vice president. J. Mark Petrash, PhD (University of Colorado) has been named president-elect; he will serve the 2010"2011 term. David Hunter, MD, PhD (Boston Hospital) and Shigeru Kinoshita, MD, PhD, FARVO (Kyoto Prefectural University) have been named vice-presidents elect and will also serve for that term.

ARVO members also voted three new section trustees to the board. John Penn, PhD, FARVO (Vanderbilt University School of Medicine) is the new Retinal Cell Biology trustee. Justine Smith, MBBS, PhD (Oregon Health Sciences University) will represent the Immunology/Microbiology Section on the board. David Williams, PhD, FARVO (University of Rochester) will represent the Visual Psychophysics & Physiological Optics Section on the board.

"I am very excited to be involved with such a dynamic organization," Delamere said. "The collaboration fostered by ARVO truly promotes its members and enhances vision and research science."

Biographical sketches

President: Nicholas Delamere, PhD, FARVODelamere, an internationally renowned authority on ion transport proteins in the eye, is a head of the Department of Physiology and a professor at the University of Arizona, which he joined in 2006. After receiving his doctorate at the University of East Anglia in his native England, Delamere brought his work on membrane transport physiology to the University of Colorado in 1976 and later moved to the University of Louisville, where he received the President's Award for Outstanding Scholarship, Research and Creative Activity. He was also a recipient of the Research to Prevent Blindness Inc. Senior Scientific Investigator Award. He has served as vice president of the International Society for Eye Research, is a past chair of the ARVO Publications Committee and has been a member of the editorial board of Investigative Ophthalmology and Visual Science since 1992 and is an ARVO Gold Fellow.

Vice President: Paul Sternberg, Jr., MD, FARVOSternberg is George W. Hale Professor and chair of the Vanderbilt Eye Institute. He oversees a clinical and laboratory research program studying the pathogenesis of age-related macular degeneration. The author and/or co-author of 225 publications, 32 chapters and two books, Sternberg completed his medical degree with honors from the University of Chicago/Pritzker School of Medicine. He is a recipient of the American Academy of Ophthalmology Senior Honor Award, the Vitreous Society Honor Award, the L.E. Brown Humanitarian Award from the Georgia Society of Ophthalmology and the Heed Ophthalmic Foundation Award. He is on the Board of Trustees at the American Academy of Ophthalmology and is a former member of the National Eye Institute's Board of Scientific Councilors. He is an ARVO Gold Fellow and currently serves on the ARVO Finance, Exhibits and Long Range Planning Committees, and previously served on the Retina Section Annual Meeting Program Committee. He is a past member of the Editorial Board of Investigative Ophthalmology and Visual Science.

President-Elect: J. Mark Petrash, PhDPetrash is a professor and vice chair of Research for the Department of Ophthalmology at the Rocky Mountain Lions Eye Institute of the University of Colorado School of Medicine. He oversees a laboratory research program studying the structure and function of the aldo-keto reductase (AKR) enzyme family among other topics. The author and/or co-author of 73 publications, Petrash received his PhD from the University of Texas Medical Branch, Galveston. He is a recipient of the Lew R. Wasserman Merit Award, the Robert E. McCormick Research Scholar Award and the Excellence in Research in Birth Defects Award from the March of Dimes. He is on the editorial board for Molecular Vision and is a former member of the National Institute of Health Center for Scientific Review. He currently serves as the Lens Section trustee and chair of the Advocacy Committee.

Vice President-Elect: David Hunter, MD, PhDHunter is the ophthalmologist-in-chief at Children's Hospital Boston and associate professor and vice chair of ophthalmology at Harvard Medical School. He has a BS in electrical engineering from Rice University (BS) and a PhD in cell biology from Baylor College of Medicine, where he also obtained his MD degree. His ophthalmology residency was at the Massachusetts Eye and Ear Infirmary, Harvard Medical School, and his fellowship in pediatric ophthalmology and strabismus was at the Wilmer Eye Institute, Johns Hopkins University, where he remained on faculty for 10 years. Hunter is the editor-in-chief of the Journal of the American Association for Pediatric Ophthalmology and Strabismus, a fellow of the American Academy of Ophthalmology and a senior fellow of the Institute for Electrical and Electronics Engineers. He is chairman of the ARVO Finance Committee and also chaired the ARVO Annual Meeting Program Committee for the Eye Movement/Strabismus/Amblyopia/Neuro-Ophthalmology section.

Vice President-Elect: Shigeru Kinoshita, MD, PhD, FARVOAfter graduating from Osaka University Medical School in 1974, Kinoshita worked from 1979 to1982 at the Eye Research Institute in Boston as a professor and department chair of ophthalmology. Currently, he is employed by the Kyoto Prefectural University of Medicine. He has been an ARVO member since 1980; serving on the ARVO Annual Meeting Program Committee (1996"1998), the IOVS Editorial Board as associate editor (2007"present), as an ARVO Trustee (2007"present) and was recently distinguished as an ARVO Gold Fellow. He is also a member of the International Society for Eye Research, American Academy of Ophthalmology, the Cornea Society, American Society of Cataract and Refractive Surgery, International Society of Refractive Surgery and the Japanese Ophthalmological Society. Kinoshita has received the Alcon Research Institute Award (1999) and the Castroviejo Medal (2008).

Retinal Cell Biology Trustee: John Penn, PhD, FARVOPenn is the Phyllis G. and William B. Snyder Professor of Ophthalmology, director of research and vice-chairman in the Department of Ophthalmology & Visual Sciences, as well as a professor in the Department of Pharmacology and in the Department of Cell & Developmental Biology at Vanderbilt University School of Medicine. Penn's lab developed one of the most widely used animal models of ocular neovascularization, and his research, involving both fundamental as well as translational studies, has been continuously funded by the NEI since 1984. Penn has received a Dolly Green Scholar Award (1992), a Lew R. Wasserman Merit Award (1996), and a Senior Scientific Investigator Award (2005) from Research to Prevent Blindness, as well as the William J. Darby Award for Excellence in Translational Research (2006) from Vanderbilt University and the honor of Fellow from ARVO (2009). He chaired a committee charged with better defining the relationship between ARVO and the International Society for Eye Research (ISER), designed and implemented the ISER Web site, and has been designated to organize and manage the overall scientific program of the ISER Congress in Montreal in 2010.

Immunology/Microbiology Trustee: Justine Smith, MBBS, PhDSmith is the Schnitzer Professor of Ophthalmic Research and associate professor of ophthalmology and cell & developmental biology at the Casey Eye Institute, Oregon Health & Science University. She obtained her MD degree at the University of Adelaide, Australia, and her PhD at Flinders University of South Australia. She has post-doctoral fellowship training at the Singapore National Eye Center, at the Casey Eye Institute and at the National Institute of Health and Medical Research (INSERM) in Paris. Smith is the immediate past chair of the ARVO Immunology/Microbiology Annual Meeting Program Committee, and she has also served on the ARVO Members-in-Training Committee and the ARVO New Services Task Force. She co-organized the 2008 ARVO Summer Eye Research Conference on ocular autoimmunity and inflammation. She is a councilor of the International Ocular Immunology Society and a member of the Executive Committee of the American Uveitis Society, and she serves on the editorial board of the newest ophthalmic research journal, the Journal of Ocular Biology, Disease and Informatics. She is a graduate of the American Academy of Ophthalmology's Leadership Development Program.

Visual Psychophysics & Physiological Optics Trustee: David Williams, PhD, FARVOWilliams received his PhD in 1979 at the University of California at San Diego. He completed a postdoctoral fellowship at Bell Laboratories before moving to the University of Rochester in 1981 as an assistant professor in the Center for Visual Science. He is currently the William G. Allyn Chair of Medical Optics and a professor of brain & cognitive sciences, optics, ophthalmology and biomedical engineering. Williams has served as the director of the Center for Visual Science since 1991. He has also served as the lead investigator for an NIH Bioengineering Research Partnership for Adaptive Optics Instrumentation and as the associate director of the Center for Adaptive Optics, an NSF Science and Technology Center. He is an editorial board member for the Journal of Vision, has served on the ARVO Annual Meeting Program Committee, and was recently distinguished as an ARVO Fellow. He has held various leadership positions within the Optical Society of America, including its Board of Trustees.

ARVO is the largest eye and vision research organization in the world. Members include more than 12,500 eye and vision researchers from over 70 countries. The Association encourages and assists research, training, publication and dissemination of knowledge in vision and ophthalmology. For more information, visit www.arvo.org.